EphA2 antibody | knockout validation | Life Technologies (ThermoFisher Scientific) 347400
DOI
//dx.doi.org/10.13070/ko.en.7.2114
Date
2017-01-23

This is a knockout-validated antibody summary, based on the publication "EPHA2 blockade overcomes acquired resistance to EGFR kinase inhibitors in lung cancer", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit polyclonal

Company: Life Technologies (ThermoFisher Scientific

Antibody: EphA2

Catalog number: 347400

Summary: Rabbit polyclonal antibody raised against a synthetic peptide corresponding to the C-terminal region of human EphA2.

Supplier recommended for WB, IP, IF, ICC and flow cytometry.

Antigen-affinity-purified.

Reacts with human and mouse EphA2.

Validation Method

Immunohistochemistry

Sample

Lung from wild-type and EphA2 knockout mice.

Primary incubation

Anti-EphA2 antibody.

Figure

Please see Figure 4 in [1].

References
  1. Amato K, Wang S, Tan L, Hastings A, Song W, Lovly C, et al. EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer. Cancer Res. 2016;76:305-18 pubmed publisher